drugset / Trial / NCT04883840
Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis
Phase 2/3
Terminated
177 enrolled
Universitaire Ziekenhuizen KU Leuven
Flemish institute of biotechnology (VIB) · collab
RandomizedCrossoverDouble-blindTreatment
Summary
* Evaluation of the microbiota modulation away from inflammation associated microbiota profile Bacteroides2 (Bact2) * Evaluation of the effect of microbiota modulation on disease activity in ulcerative colitis and Crohn's disease patients.
Timeline
- Start
- 2020-10-22
- Primary completion
- 2025-10-11
- Completion
- 2025-10-11
Outcome
Outcome not reported
Stopped: “Due to the university's termination of its contract with the online questionnaire platform, we decided to discontinue the study before reaching the anticipated sample size.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 10 mg | — |